Management ChangeAug 3, 2026, 07:36 AM
Ascentage Pharma Appoints New Chief Business and Commercial Officers
AI Summary
Ascentage Pharma Group International announced the appointment of Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer. These strategic hires aim to strengthen the company's global business development and establish a dedicated US commercialization function. Both executives bring extensive experience in the biopharmaceutical industry and will report to the Chairman and CEO, Dr. Dajun Yang, as the company enters a new phase of global expansion.
Key Highlights
- Ascentage Pharma appointed Dr. Faiçal Miyara as Chief Business Officer (CBO).
- Dr. Miyara will be responsible for the Company's global business development.
- Ascentage Pharma appointed Jim Ziegler as Chief Commercial Officer (CCO).
- Mr. Ziegler will oversee commercialization in the US and other countries outside China.
- Both new officers will report directly to Dr. Dajun Yang, Chairman and CEO.
- Dr. Miyara brings over 20 years of oncology-focused business development experience.
- Mr. Ziegler has over 25 years of commercial and operational leadership experience in biopharma.
Price Impact
More from AAPG